This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), to Integrated Clinical Systems, Inc. The contract provides for annual software maintenance and renewal of an unlimited site license for the JReview and other clinical data review software products developed by Integrated Clinical Systems. The contract has a total ceiling value of $124,980.00 and an ultimate completion date of June 30, 2021....
Integrated Clinical Systems, Inc. was awarded a one-year, firm fixed price purchase order valued at $25,000 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The contract is for software renewal in support of the agency's biomedical research mission. Place of performance will be the prime contractor's offices in Frenchtown, New Jersey. No subcontractors or set aside designations were identified. This purchase...
This is a $886,246.31 firm-fixed-price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Integrated Clinical Systems, Inc., a for-profit Subchapter S Corporation. The contract is for JReview task order services under the Integrated Clinical Systems HHSF223201510041I contract vehicle. JReview is a software product that supports risk-based monitoring and analytics for clinical trials. Integrated Clinical Systems has provided similar...
The Department of Health and Human Services' Food and Drug Administration awarded a firm fixed price delivery order contract to Integrated Clinical Systems, Inc., a for-profit Subchapter S corporation, for JREVIEW SERVICES. The contract, valued at $826,997.10, has a completion date of September 21, 2018 and was awarded on August 23, 2017. Integrated Clinical Systems has previously provided software licensing, maintenance, and enhancement services in support of clinical trials data management...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Integrated Clinical Systems, Inc., a for-profit Subchapter S Corporation. The contract, valued at $779,593.50, is for the provision of software licensing, maintenance, and enhancement services in support of clinical trials data management. Integrated Clinical Systems has previously provided similar services to the National Cancer Institute and the FDA's Center for Drug Evaluation and Research....
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Clinical Systems, Inc., a for-profit Subchapter S corporation, for CDER JReview support and services. The contract has a total ceiling value of $895,543.64 and a period of performance through September 21, 2017. Integrated Clinical Systems, Inc. provides data visualization, analysis, and review tools for clinical trials, and has previously held prime contracts with the National Institutes of...
This is a $14,790.00 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of laboratory supplies to support NCI's cancer research programs, clinical trials, and patient care initiatives. The contract does not have a set-aside designation, indicating open competition. Intera...
This is a $28,633,322.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Information Management Services, Inc. (IMS), a for-profit subchapter S corporation. The contract is for services related to data modeling, acquisition, and management; data analytics, including statistical programming and bioinformatics; and tool and software development. The contract has a base period from...
This is a $28,735,975.00 cost-plus-fixed-fee delivery order awarded to Information Management Services, Inc. (IMS) by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS). The contract is for biomedical information management and analytical support services, and it has an ultimate completion date of March 15, 2025. The contract is a task order under a larger $149.9 million indefinite delivery contract (IDC) that IMS holds with NCI to...
This is a $118,000.00 delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Information Management Services, Inc. (IMS), a for-profit Subchapter S corporation. The contract is for time and materials services and does not have a set-aside designation. IMS has significant experience providing analytic, data management, IT, and clinical trial support services to federal agencies, particularly HHS and its...